Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention
4. januar 2022 opdateret af: Duke University
A Patient-Caregiver Behavioral Intervention for Older Adults With Cancer and Mild Cognitive Impairment
The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns.
Participant and their spouse or participant and their family caregiver will have six, 60-minute video-conference sessions which will be scheduled at their convenience.
The investigator will loan participants a tablet computer (iPad) to use for videoconferencing and train the participant in its use.
Participant and their spouse or participant and their family caregiver will complete three assessments - one before starting the sessions, one after the sixth session, and one after 1 month.
Each assessment will include surveys, which the participant will complete separately from their spouse or family caregiver.
For most people, it will take upwards of 2 - 4 months to complete this study.
Studieoversigt
Status
Trukket tilbage
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27705
- Duke University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 100 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
Patient inclusion criteria include:
- Patients with Stage I-IV breast, colon, rectal, or lung cancer (newly diagnosed within 6 months; age 65 or older.
- Participants must be living at home (either in her/his own home).
- Participants must be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
- Exhibit Mild Cognitive Impairment.
- Have an informal family caregiver.
Inclusion Criteria:
(Partner or family member) inclusion criteria include:
- Caregivers are 18 older.
- Be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
- Either co-reside with the patient or spend at least 3-4 hours day caregiving.
- Not exhibit cognitive impairment.
Exclusion Criteria for both patients and caregivers:
- Participant has visual or hearing impairments that preclude participation.
- Participant has dementia and do not have the capacity to participate.
- Have a serious untreated psychiatric illness as documented in medical chart review.
- The patient and the caregiver score less than a 3 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) on a scale 0 to 10 to screen for distress.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Patientplejer Dyad
Deltagere, der er 65 år eller ældre med kræft og let kognitiv svækkelse med deres pårørende.
|
Six sixty minute sessions that teaches participants distress and communication coping skills.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of completed sessions as measured by enrollment log
Tidsramme: Up to 10 weeks
|
Up to 10 weeks
|
|
|
Number of participants who are satisfied with the intervention as measured by a score of 24 or greater on the CSQ-8
Tidsramme: Up to 10 weeks.
|
The Client Satisfaction Questionnaire (CSQ-8) is a self report measure of satisfaction with health and behavioral services received.
The CSQ-8 is measured on a four point Likert scale from 1 "Quite Dissatisfied" to 4 "Very Satisfied."
Scores range from 8-32, with higher values indicating higher satisfaction.
|
Up to 10 weeks.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Distress as measured by the DASS-21
Tidsramme: Up to 10 weeks.
|
The Depression, Anxiety, and Stress Scale (DASS-21) measure will be used for rating general distress across three emotional states of depression, anxiety, and stress.
The measure has a total of 21 items.
Scores range from 0- 63, with higher scores indicating greater distress.
|
Up to 10 weeks.
|
|
Change in Quality of Life as measured by the FACT-G
Tidsramme: Up to 10 weeks.
|
The Functional Assessment of Cancer Therapy: General (FACT-G) measure will be used for rating quality of life.
The measure has a total of 27 items.
Scores range from 0-108, with higher scores indicating greater quality of life.
|
Up to 10 weeks.
|
|
Change in Communication Patterns as measured by the CPQ-SF
Tidsramme: Up to 10 weeks.
|
The Communication Patterns Questionnaire Short-Form (CPQ-SF) will be used for rating communication patterns in a relationship.
The measure has a total of 11 items.
Scores range from 11-99, higher scores indicate a greater likelihood of using a particular communication pattern during conflict interactions.
|
Up to 10 weeks.
|
|
Change in Relationship Satisfaction as measured by the Mutuality Scale of the Family Care Inventory
Tidsramme: Up to 10 weeks.
|
The Mutuality Scale of the Family Care Inventory will be used for rating mutual concerns and overall relationship satisfaction.
The measure consists of 15 items.
Scores range from 0-60, higher scores indicate greater relationship satisfaction.
|
Up to 10 weeks.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
15. januar 2022
Primær færdiggørelse (Forventet)
30. november 2026
Studieafslutning (Forventet)
30. november 2026
Datoer for studieregistrering
Først indsendt
29. marts 2021
Først indsendt, der opfyldte QC-kriterier
29. marts 2021
Først opslået (Faktiske)
1. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
19. januar 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
4. januar 2022
Sidst verificeret
1. januar 2022
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Pro00107680
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .